SB
NeuroTrauma Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NTS-104 | Acute Ischemic Stroke (AIS) | Phase 1 |
Leadership Team at NeuroTrauma Sciences
MD
Marc de Somer, MD, ScD, MSc, MPH, MBA
Chief Medical Officer
TP
Tom Parry, PhD, MBA
Chief Scientific Officer
| Drug | Indication | Phase |
|---|---|---|
| NTS-104 | Acute Ischemic Stroke (AIS) | Phase 1 |